CMR plans to begin US commercial activities for its Versius robots in 2026. Image credit: T. Schneider via Shutterstock.com. CMR Surgical has secured US Food and Drug Administration (FDA) clearance ...

CMR Surgical Ltd. hopes to soon gain U.S. FDA 510(k) clearance for its Versius Plus surgical robotic system to bring it to the U.S. market amid rising demand for robotic surgery. Although the ...

CMR Surgical’s Versius surgical robot has received a European CE and UKCA marks for paediatric surgery, unlocking a new market segment for the UK-based company. Building on the CE mark initially ...

Javascript is required for you to be able to read premium content. Please enable it in your browser settings.

Soft tissue robotic systems designed to improve surgical precision are expanding into new specialties and increasing ...

CMR Surgical Ltd. secured more than $200 million in funding to bring its surgical robotic system, Versius, to the U.S. market and expand elsewhere. The financing, which came in the form of equity and ...

KNOXVILLE, Tenn. (WATE) — One of the potential drawbacks of robotic surgery is that a surgeon has to rely on visual information to determine how much force to use with their instruments, but a new ...

Small, modular design of the Versius system supports use in robotic-assisted paediatric surgery Cambridge, UK - 8 January 2026, CMR Surgical ('CMR' or 'the Company'), the global surgical robotics ...